Open Date
01 Sep 2025
Close Date
03 Sep 2025
Listing Date
09 Sep 2025
Max Investment
₹1,94,922
Price Range
₹120 - ₹126
Lot Size
-
IPO Size
₹126Cr
Exchange Symbols


Open Date
Close Date
Listing Date
Max Investment
Price Range
Lot Size
IPO Size
Exchange Symbols
Well established manufacturer of pharmaceutical formulations with diverse product portfolio and diverse market.
Large manufacturing capabilities.
Wide Domestic and International Marketing Network.
Experienced management team supported by large, diverse and skilled work force.
We are a pharmaceutical company engaged in developing, manufacturing and marketing a diverse range of sterile liquid products - parenteral products, being packed in plastic container with Aseptic Blow-Fill-Seal ("ABFS") and Injection Strech Blow Moulding ("ISBM") technology. We manufacture large volume parenterals ("LVPs") and small volume parenterals ("SVPs") in six therapeutic segments. In addition to that, we also manufacturer medical devices. We manufacture fluid therapy - (IV Fluid), formulations, diluents, ophthalmic, respiratory care and irrigation solutions in therapeutic segment and products like irrigation, first-aid solution, eye lubricants etc. in medical device segment. We offer wide range of closure systems, such as nipple head, twist-off, leur-lock and screw types and container fill-volume ranging from 2ml to 1000 ml. Our formulation and development operations help us to develop new formulation as well as modify improve the formulation for our own brand as well as our customers for product partnering business. We have a dedicated Formulation and Development ("F&D") and quality control laboratory located at our manufacturing facility in Hariyala, District Kheda, Gujarat, India. We have four LVPs manufacturing lines, which include two lines of conventional single port containers with ABFS technology and two lines for SteriPort products with ISBM technology. Similarly, we have three operational SVPs manufacturing lines, which includes two ABFS lines and one conventional three-piece container filling lines. Our manufacturing facility has good manufacturing practices ("GMP") certifications from the Food & Drugs Control Administration, Gujarat, in conformity with the format recommended by the World Health Organization (the "WHO"), the GMP for formulations from Cambodia, Sudan, Philippines, Zimbabwe. We also have certificate from DNV for exports of medical device products. Our cGMP capabilities allow us to offer our customers various products of sterile liquid form in product categories of quinolones, anti-biotics, anti-fungal, diuretic, anti-anaerobic, Ophthalmic, Respiratory etc.
Amanta Healthcar: IPO Dates
The Amanta Healthcar IPO opens for subscription on 01 Sep 2025, and closes on 03 Sep 2025. Investors will likely receive their allotment status updates on 04 Sep 2025. Those who get allotted shares can expect them credited to their Demat accounts by 08 Sep 2025. The shares will be officially listed on the stock exchange on 09 Sep 2025.
Amanta Healthcar: IPO Price Band
The IPO consists of a fresh issue and an offer for sale, with a price band set between ₹120.0 and ₹126.0 per share.Investors can apply within this range. This book-building issue includes a fresh issue worth ₹126.0 crore and an offer for sale valued at ₹ - crore. The exact listing price will be revealed on 09 Sep 2025, which is when the shares start trading on the exchange.
Amanta Healthcar: Lot Size and Issue Size
The minimum application lot size is shares, and investors need to apply for at least one lot. The total IPO size is approximately ₹126Cr crore.
You will also get notified of your allotment via push notifications and email from Torus Digital.

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Congratulations,
Your Digital savings bank account opening journey is complete.